fluoxetine has been researched along with Hypochondriacal Neuroses in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prior studies of hypochondriasis demonstrated benefits for pharmacotherapy and for cognitive-behavioral therapy (CBT)." | 2.84 | A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis. ( Ahern, DK; Barsky, AJ; Fallon, BA; Pavlicova, M; Skritskya, N; Slavov, I, 2017) |
| "Fluoxetine is a moderately effective and well-tolerated treatment for hypochondriasis." | 2.73 | A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. ( Cheng, J; Fallon, BA; Liebowitz, MR; Petkova, E; Sanchez-Lacay, A; Schneier, F; Skritskaya, N; Vermes, D, 2008) |
| "Given marked similarities between hypochondriasis and obsessive-compulsive disorder, we decided to conduct an open trial of high-dose fluoxetine for patients with DSM-III-R hypochondriasis who did not meet criteria for major depression." | 2.67 | Fluoxetine for hypochondriacal patients without major depression. ( Fallon, BA; Hollander, E; Jusino, C; Klein, DF; Liebowitz, MR; Salmán, E; Schneier, FR, 1993) |
| "Persistence of hypochondriasis was individually predicted by longer duration of prior hypochondriasis (P = 0." | 1.37 | Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. ( Fallon, BA; Pavlicova, M; Schweitzer, PJ; Zafar, U, 2011) |
| "Hypochondriasis is a disorder for which there are no established effective treatments." | 1.28 | Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment. ( Fallon, BA; Hollander, E; Javitch, JA; Liebowitz, MR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fallon, BA | 5 |
| Ahern, DK | 1 |
| Pavlicova, M | 2 |
| Slavov, I | 1 |
| Skritskya, N | 1 |
| Barsky, AJ | 1 |
| Petkova, E | 1 |
| Skritskaya, N | 1 |
| Sanchez-Lacay, A | 1 |
| Schneier, F | 1 |
| Vermes, D | 1 |
| Cheng, J | 1 |
| Liebowitz, MR | 3 |
| Schweitzer, PJ | 1 |
| Zafar, U | 1 |
| Talarowska, M | 1 |
| Zboralski, K | 1 |
| Chamielec, M | 1 |
| Gałecki, P | 1 |
| Salmán, E | 1 |
| Schneier, FR | 1 |
| Jusino, C | 1 |
| Hollander, E | 2 |
| Klein, DF | 1 |
| Javitch, JA | 1 |
| Viswanathan, R | 1 |
| Paradis, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Hypochondriasis With CBT and/or SSRI[NCT00339079] | Phase 1/Phase 2 | 195 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Whitley index is a self-report measure of hypochondriasis H-YBOCS-M is an independent evaluator structured assessment of hypochondriasis (NCT00339079)
Timeframe: Measured at Week 24
| Intervention | Participants (Count of Participants) |
|---|---|
| Cognitive Behavioral Therapy (CBT) | 21 |
| Placebo | 13 |
| Fluoxetine | 20 |
| Combined CBT and Fluoxetine | 25 |
3 trials available for fluoxetine and Hypochondriacal Neuroses
| Article | Year |
|---|---|
A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis.
Topics: Adult; Aged; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Humans; Hy | 2017 |
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
Topics: Adult; Aged; Connecticut; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; | 2008 |
Fluoxetine for hypochondriacal patients without major depression.
Topics: Adult; Female; Fluoxetine; Humans; Hypochondriasis; Male; Psychiatric Status Rating Scales | 1993 |
4 other studies available for fluoxetine and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment.
Topics: Adolescent; Adult; Aged; Child Abuse; Clinical Trials as Topic; Diagnostic and Statistical Manual of | 2011 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochond | 2011 |
Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment.
Topics: Adult; Aged; Comorbidity; Female; Fluoxetine; Humans; Hypochondriasis; Male; Middle Aged; Obsessive- | 1991 |
Treatment of cancer phobia with fluoxetine.
Topics: Adult; Female; Fluoxetine; Humans; Hypochondriasis; Neoplasms; Obsessive-Compulsive Disorder | 1991 |